Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction
Alter DA, Ko DT, Newman A, Tu JV. Eur Heart J. 2006; 27(13):1539-49. Epub 2006 Jun 7.
Publications
Study design to determine the effects of widespread restrictions on hospital utilization to control an outbreak of SARS in Toronto, Canada
Schull MJ, Stukel TA, Vermeulen MJ, Alter D. Exp Rev Pharmacoecon Outcome Res. 2006; 6(3):285-92.
Persistence with bisphosphonate therapy in older people
Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M. J Am Geriatr Soc. 2006; 54(6):1015-6.
Registry of the Canadian Stroke Network: Report on the 2002/03 Ontario Stroke Audit
How many “me-too” drugs are enough? The case of physician preferences for specific statins
Austin PC, Mamdani MM, Juurlink DN. Ann Pharmacother. 2006; 40(6):1047-51. Epub 2006 May 16.
Aspirin use and outcomes in a community-based cohort of 7,352 patients discharged after first hospitalization for heart failure
McAlister FA, Ghali WA, Gong Y, Fang J, Armstrong PW, Tu JV. Circulation. 2006; 113(22):2572-8. Epub 2006 May 30.
Variation in recruitment across sites in a consent-based clinical data registry: lessons from the Canadian Stroke Network
Willison DJ, Kapral MK, Peladeau P, Richards JA, Fang J, Silver FL. BMC Med Ethics. 2006; 7:E6.
The Smoking Regulatory Index: a new way to measure public health performance
Rosenfield D, Manuel DG, Alter DA. CMAJ. 2006; 174(10):1403-4.
Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality
Austin PC, Mamdani MM, Juurlink DN, Alter DA, Tu JV. Am Heart J. 2006; 151(5):969-75.
Access to Health Services in Ontario: ICES Atlas. 2nd Edition
Tu JV, Pinfold SP, McColgan P, Laupacis A, editors. May 2006